Financhill
Sell
15

MGIH Quote, Financials, Valuation and Earnings

Last price:
$1.44
Seasonality move :
-1.88%
Day range:
$1.43 - $1.49
52-week range:
$0.98 - $9.57
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.42x
P/B ratio:
0.52x
Volume:
15.9K
Avg. volume:
19.1K
1-year change:
30.5%
Market cap:
$16.2M
Revenue:
$38.5M
EPS (TTM):
-$0.78
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue -- $64.6M $66.2M $45.6M $38.5M
Revenue Growth (YoY) -- -- 2.58% -31.15% -15.5%
 
Cost of Revenues -- $47.2M $50M $36.5M $30.2M
Gross Profit -- $17.4M $16.3M $9.1M $8.3M
Gross Profit Margin -- 26.88% 24.57% 19.88% 21.55%
 
R&D Expenses -- -- $305K $241.2K $261.8K
Selling, General & Admin -- $12.3M $10.1M $9.6M $14.7M
Other Inc / (Exp) -- -$189.6K -$135.3K $1.3M -$676.2K
Operating Expenses -- $12.3M $10.7M $10.1M $15.2M
Operating Income -- $5.1M $5.5M -$1.1M -$6.9M
 
Net Interest Expenses -- $444.7K $425.8K $684.4K $958.9K
EBT. Incl. Unusual Items -- $4.5M $5M -$431.4K -$8.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $800.1K $897.2K -$77.3K $206.9K
Net Income to Company -- $3.7M $4.1M -$354.1K -$8.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- $3.7M $4.1M -$354.1K -$8.8M
 
Basic EPS (Cont. Ops) -- $0.37 $0.41 -$0.03 -$0.78
Diluted EPS (Cont. Ops) -- $0.37 $0.41 -$0.03 -$0.78
Weighted Average Basic Share -- $10M $10M $10.3M $11.3M
Weighted Average Diluted Share -- $11.3M $11.3M $10.3M $11.3M
 
EBITDA -- $7M $7.3M $2M -$6.2M
EBIT -- $4.9M $5.4M $253K -$7.6M
 
Revenue (Reported) -- $64.6M $66.2M $45.6M $38.5M
Operating Income (Reported) -- $5.1M $5.5M -$1.1M -$6.9M
Operating Income (Adjusted) -- $4.9M $5.4M $253K -$7.6M
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue -- -- $66.2M $45.6M $38.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- $50M $36.5M $30.2M
Gross Profit -- -- $16.3M $9.1M $8.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- $10.1M $9.6M $14.7M
Other Inc / (Exp) -- -- -$135.3K $1.3M -$676.2K
Operating Expenses -- -- $10.7M $10.1M $15.2M
Operating Income -- -- $5.5M -$1.1M -$6.9M
 
Net Interest Expenses -- -- $425.8K $684.4K $958.9K
EBT. Incl. Unusual Items -- -- $5M -$431.4K -$8.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- $897.2K -$77.3K $206.9K
Net Income to Company -- -- $4.1M -$354.1K -$8.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- $4.1M -$354.1K -$8.8M
 
Basic EPS (Cont. Ops) -- -- $0.41 -$0.03 -$0.78
Diluted EPS (Cont. Ops) -- -- $0.41 -$0.03 -$0.78
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- $7.3M $2M -$6.2M
EBIT -- -- $5.4M $252.9K -$7.6M
 
Revenue (Reported) -- -- $66.2M $45.6M $38.5M
Operating Income (Reported) -- -- $5.5M -$1.1M -$6.9M
Operating Income (Adjusted) -- -- $5.4M $252.9K -$7.6M
Period Ending 2021-12-23 2022-12-23 2023-12-23 2024-12-23 2025-12-23
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Cash and Equivalents -- $20.7M $18.8M $27.6M $13.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- $17.6M $18.1M $10.3M $9.5M
Inventory -- $9.7M $9.8M $5.6M $3.7M
Prepaid Expenses -- $1M $890.3K $790.9K $892.7K
Other Current Assets -- -- -- -- --
Total Current Assets -- $52.5M $48.3M $44.5M $27.8M
 
Property Plant And Equipment -- $17.5M $14.9M $12.1M $11.3M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- $1.9M $2.1M $1.8M $4.1M
Total Assets -- $72.7M $66M $59M $43.6M
 
Accounts Payable -- $4.9M $5.7M $3.4M $3.6M
Accrued Expenses -- $1.8M $1.6M $704.5K $567.1K
Current Portion Of Long-Term Debt -- $1.9M -- -- --
Current Portion Of Capital Lease Obligations -- $777.6K $772.5K $157.5K $218.6K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- $41.3M $25.8M $19.1M $12.1M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- $42.2M $25.9M $19.1M $12.6M
 
Common Stock -- $20K $20K $22.5K $22.5K
Other Common Equity Adj -- $1.1M $320.5K -$2.7M -$2.8M
Common Equity -- $30.5M $40.1M $39.9M $31M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- $30.5M $40.1M $39.9M $31M
 
Total Liabilities and Equity -- $72.7M $66M $59M $43.6M
Cash and Short Terms -- $20.7M $18.8M $27.6M $13.3M
Total Debt -- $18.7M $15.8M $13.4M $5.6M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Cash and Equivalents -- -- $18.8M $27.6M $13.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- $18.1M $10.3M $9.5M
Inventory -- -- $9.8M $5.6M $3.7M
Prepaid Expenses -- -- $890.3K $790.9K $892.7K
Other Current Assets -- -- -- -- --
Total Current Assets -- -- $48.3M $44.5M $27.8M
 
Property Plant And Equipment -- -- $14.9M $12.1M $11.3M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- $2.1M $1.8M $4.1M
Total Assets -- -- $66M $59M $43.6M
 
Accounts Payable -- -- $5.7M $3.4M $3.6M
Accrued Expenses -- -- $1.6M $704.5K $567.1K
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- $772.5K $157.5K $218.6K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- $25.8M $19.1M $12.1M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- $25.9M $19.1M $12.6M
 
Common Stock -- -- $20K $22.5K $22.5K
Other Common Equity Adj -- -- $320.5K -$2.7M -$2.8M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- $40.1M $39.9M $31M
 
Total Liabilities and Equity -- -- $66M $59M $43.6M
Cash and Short Terms -- -- $18.8M $27.6M $13.3M
Total Debt -- -- $15.8M $13.4M $5.6M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders -- $3.7M $4.1M -$354.1K -$8.8M
Depreciation & Amoritzation -- $2.1M $1.9M $1.7M $1.4M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -$1.4M -$1.4M $6.7M $688.3K
Change in Inventories -- -$1.4M -$633K $3.4M $1.3M
Cash From Operations -- $5.3M $2M $8.1M -$4.1M
 
Capital Expenditures -- $1.2M $540.6K $216.5K $2.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$1.5M $2.1M -$216.5K -$2.2M
 
Dividends Paid (Ex Special Dividend) -- -- -$8.9M -- --
Special Dividend Paid
Long-Term Debt Issued -- $17.5M $26.4M $16.2M $14.2M
Long-Term Debt Repaid -- -$24.8M -$29.2M -$18.7M -$22M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- $6M -- --
Cash From Financing -- -$7.3M -$5.6M $1.8M -$7.9M
 
Beginning Cash (CF) -- $23.4M $21.3M $19.4M $27.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -$3.4M -$1.5M $9.7M -$14.2M
Ending Cash (CF) -- $21.3M $19.4M $27.6M $13.3M
 
Levered Free Cash Flow -- $4.1M $1.5M $7.9M -$6.5M
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders -- -- $4.1M -$354.1K -$8.8M
Depreciation & Amoritzation -- -- $1.9M $1.7M $1.4M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -$1.4M $6.7M $688.3K
Change in Inventories -- -- -$633K $3.4M $1.3M
Cash From Operations -- -- $2M $8.1M -$4.1M
 
Capital Expenditures -- -- $540.6K $216.5K $2.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- $2.1M -$216.5K -$2.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $26.4M $16.2M $14.2M
Long-Term Debt Repaid -- -- -$29.2M -$18.7M -$22M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- $6M -- --
Cash From Financing -- -- -$5.6M $1.8M -$7.9M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -$1.9M $8.6M -$14.5M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- $1.5M $7.9M -$6.5M
Period Ending 2021-12-23 2022-12-23 2023-12-23 2024-12-23 2025-12-23
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock